Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283257461> ?p ?o ?g. }
- W4283257461 endingPage "799" @default.
- W4283257461 startingPage "788" @default.
- W4283257461 abstract "As the therapeutic regimens against the COVID-19 remain scarce, the microRNAs (miRNAs) can be exploited to generate efficient therapeutic targets. The miRNAs have been found to play pivotal roles in the several regulatory functions influencing the prognosis of viral infection. The miRNAs have a prospective role in the up and down regulation of the ACE2 receptors. This review examines the clinical applications, as well as the possible threats associated with the use of miRNAs to combat the deleterious consequences of SARS-CoV-2 infection.This article was compiled to evaluate how the miRNAs are involved in the SARS-CoV-2 pathogenesis and infection, and their potential functions which could help in the development of therapeutic targets against the COVID-19. The sources of the collected information include the several journals, databases and scientific search engines such as the Google scholar, Pubmed, Science direct, official website of WHO, among the other sites. The investigations on the online platform were conducted using the keywords miRNA biogenesis, miRNA and ACE2 interaction, therapeutic role of miRNAs against SARS-CoV-2 and miRNA therapy side effects.This review has highlighted that the miRNAs can be exploited to generate potential therapeutic targets against the COVID-19. Changes in the miRNA levels following viral replication are an essential component of the host response to infection. The collection and modification of miRNA modulates may help to minimize the deleterious consequences of SARS-CoV-2 infection, such as by controlling or inhibiting the generation of cytokines and chemokines. The degradation of viral RNA by the cellular miRNAs, along with the reduced expression of ACE2 receptors, can substantially reduce the viral load. Specific miRNAs have been found to have an antiviral influence, allowing the immune system to combat the infection or forcing the virus into a latency stage.This review summarizes several studies revealing the involvement of miRNAs in diverse and complex processes during the infection process of SARS-CoV-2. The miRNAs can substantially reduce the viral load by degradation of viral RNA and reduced expression of ACE2 receptors, besides mitigating the deleterious consequences of the exaggerated secretion of cytokines. Extensive investigations need to be done by the scientific community to utilize the miRNA based strategies for the development of effective therapeutic targets against the COVID-19." @default.
- W4283257461 created "2022-06-23" @default.
- W4283257461 creator A5001467887 @default.
- W4283257461 creator A5007802961 @default.
- W4283257461 creator A5009250229 @default.
- W4283257461 creator A5022302938 @default.
- W4283257461 creator A5033858829 @default.
- W4283257461 creator A5051482741 @default.
- W4283257461 creator A5055119416 @default.
- W4283257461 creator A5068838335 @default.
- W4283257461 creator A5075749258 @default.
- W4283257461 date "2022-07-01" @default.
- W4283257461 modified "2023-09-26" @default.
- W4283257461 title "MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review" @default.
- W4283257461 cites W1493754322 @default.
- W4283257461 cites W1597636635 @default.
- W4283257461 cites W161540545 @default.
- W4283257461 cites W1966238900 @default.
- W4283257461 cites W1980269624 @default.
- W4283257461 cites W1982752738 @default.
- W4283257461 cites W2006247279 @default.
- W4283257461 cites W2019130238 @default.
- W4283257461 cites W2030300755 @default.
- W4283257461 cites W2033279061 @default.
- W4283257461 cites W2041286686 @default.
- W4283257461 cites W2045402423 @default.
- W4283257461 cites W2059382687 @default.
- W4283257461 cites W2060860407 @default.
- W4283257461 cites W2080118328 @default.
- W4283257461 cites W2095429824 @default.
- W4283257461 cites W2098671498 @default.
- W4283257461 cites W2105686255 @default.
- W4283257461 cites W2112121037 @default.
- W4283257461 cites W2128882718 @default.
- W4283257461 cites W2142718844 @default.
- W4283257461 cites W2146642335 @default.
- W4283257461 cites W2150395782 @default.
- W4283257461 cites W2167232191 @default.
- W4283257461 cites W2168230240 @default.
- W4283257461 cites W2170139221 @default.
- W4283257461 cites W2404457973 @default.
- W4283257461 cites W2468459975 @default.
- W4283257461 cites W2508381005 @default.
- W4283257461 cites W2528044351 @default.
- W4283257461 cites W2554050349 @default.
- W4283257461 cites W2560198845 @default.
- W4283257461 cites W2748577514 @default.
- W4283257461 cites W2750079969 @default.
- W4283257461 cites W2775909410 @default.
- W4283257461 cites W2780228539 @default.
- W4283257461 cites W2811212358 @default.
- W4283257461 cites W2868772566 @default.
- W4283257461 cites W2891009119 @default.
- W4283257461 cites W2908887980 @default.
- W4283257461 cites W2913085849 @default.
- W4283257461 cites W2915433652 @default.
- W4283257461 cites W2963934840 @default.
- W4283257461 cites W3001465255 @default.
- W4283257461 cites W3007160431 @default.
- W4283257461 cites W3009424226 @default.
- W4283257461 cites W3009912996 @default.
- W4283257461 cites W3013008917 @default.
- W4283257461 cites W3014912119 @default.
- W4283257461 cites W3017680297 @default.
- W4283257461 cites W3018037557 @default.
- W4283257461 cites W3024407506 @default.
- W4283257461 cites W3033005856 @default.
- W4283257461 cites W3033192367 @default.
- W4283257461 cites W3034708975 @default.
- W4283257461 cites W3035333425 @default.
- W4283257461 cites W3039798227 @default.
- W4283257461 cites W3041266812 @default.
- W4283257461 cites W3046992876 @default.
- W4283257461 cites W3047678055 @default.
- W4283257461 cites W3048490071 @default.
- W4283257461 cites W3049068517 @default.
- W4283257461 cites W3070401590 @default.
- W4283257461 cites W3081613837 @default.
- W4283257461 cites W3084085407 @default.
- W4283257461 cites W3087149315 @default.
- W4283257461 cites W3089018088 @default.
- W4283257461 cites W3092836060 @default.
- W4283257461 cites W3095822337 @default.
- W4283257461 cites W3100411621 @default.
- W4283257461 cites W3100904172 @default.
- W4283257461 cites W3107339195 @default.
- W4283257461 cites W3108150708 @default.
- W4283257461 cites W3108893401 @default.
- W4283257461 cites W3109754638 @default.
- W4283257461 cites W3110695823 @default.
- W4283257461 cites W3112217597 @default.
- W4283257461 cites W3112267440 @default.
- W4283257461 cites W3116580066 @default.
- W4283257461 cites W3117154968 @default.
- W4283257461 cites W3117520257 @default.
- W4283257461 cites W3118438588 @default.
- W4283257461 cites W3131456650 @default.
- W4283257461 cites W3137546213 @default.